The consensus statement on the locoregional treatment of abdominal sarcomatosis

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 291-294

  Rossi, Carlo Riccardo ^a   Casali, Paolo ^b   Kusamura, Shigeki ^b   Baratti, Dario ^b   Deraco, Marcello ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Abdominal sarcomatosis; Consensus; Local regional therapy

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; GEMCITABINE; IFOSFAMIDE; IMATINIB;

ABDOMINAL SARCOMATOSIS; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CONFERENCE PAPER; CONSENSUS; CYTOREDUCTIVE SURGERY; DRUG ADMINISTRATION ROUTE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; LOCAL THERAPY; MEDICAL EXPERT; METHODOLOGY; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; REGIONAL THERAPY; SOFT TISSUE SARCOMA;

ABDOMINAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CONSENSUS; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PRACTICE GUIDELINES AS TOPIC; SARCOMA;

EID: 50849099545     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21067     Document Type: Conference Paper

References (24)

1. Bilimoria MM, Holtz DJ, Mirza NQ, et al.: Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002;94:2441-2446.
2. Pirayesh A, Chee Y, Helliwell T, et al.: The management of retroperitoneal soft tissue sarcoma: A single institution experience with a review of the literature. Eur J Surg Oncol 2001;27:491-497.
3. Sindelar WF, Kinsella TJ, Chen PW, et al.: Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993;128:402-410.
4. Plaat BE, Hollema H, Molenaar WM, et al.: Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 2000;18:3211-3220.
5. Weichselbaum RR, Beckett MA, Hallahan DE, et al.: Molecular targets to overcome radioresistance. Semin Oncol 1992;19:14-20.
6. Markman M: Intraperitoneal drug delivery of antineoplastics. Drugs 2001;61:1057-1065.
7. Sugarbaker P: Peritoneal carcinomatosis: Principles of management. Boston: Kluwer; 1996.
8. Spratt JS, Adcock RA, Muskovin M, et al.: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256-260.
9. Verwaal VJ, Ruth SV, De Bree E, et al.: Randomized trial of cytoreduction and hypertermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743.
10. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:1.
11. Berthet B, Sugarbaker TA, Chang D, et al.: Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 1999;35:413-419.
12. Eilber FC, Rosen G, Forscher C, et al.: Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sacrcoma. Ann Surg Oncol 1999;6:645-650.
13. Bonvalot S, Cavalcanti A, Le Péchoux C, et al.: Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 2005;31:917-923.
14. Rossi CR, Deraco M, De Simone M, et al.: Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: Clinical outcome and prognostic factors in 60 consecutive patients. Cancer 2004;100:1943-1950.
15. Sugarbaker PH: Peritonectomy procedure. Ann Surg 1995;221:29-42.
16. Rossi CR, Foletto M, Mocellin S, et al.: Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase I study. Cancer 2002;94:492-499.
17. Sugarbaker PH, Stuart OA: Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan. Cancer Chemother Pharmacol 2007;59:151-155. Epub, 2006.
18. Eilber FC, Rosen G, Forscher C, et al.: Recurrent gastrointestinal stromal sarcomas. Surg Oncol 2000;9:71-75.
19. Eilber FC, Rosen G, Forscher C, et al.: Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol 1999;6:645-650.
20. Yoshida Y, Inoue K, Ohsako T, et al.: Weekly paclitaxel therapy is curative for patients with retroperitoneal liposarcoma. Gan To Kagaku Ryoho 2007;34:465-467.
21. Edmonson JH, Ebbert LP, Nascimento AG, et al.: Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol 1996;19:574-576.
22. Van Hoesel QG, Verweij J, Catimel G, et al.: Phase II study with docetaxel (taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 1994;5:539-542.
23. Elias D, Bonnay M, Puizillou JM, et al.: Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: Pharmacokinetics and tissue distribution. Ann Oncol 2002;13:267-272.
24. Bartlett DL, Buell JF, Libutti SK, et al.: A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer 1998;83:1251-1261.